Literature DB >> 29197658

Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.

Daniel J Clemens1, Anne R Lentino1, Jamie D Kapplinger2, Dan Ye3, Wei Zhou3, David J Tester3, Michael J Ackerman4.   

Abstract

BACKGROUND: Mutations in the KCNQ1-encoded Kv7.1 potassium channel cause long QT syndrome (LQTS) type 1 (LQT1). It has been suggested that ∼10%-20% of rare LQTS case-derived variants in the literature may have been published erroneously as LQT1-causative mutations and may be "false positives."
OBJECTIVE: The purpose of this study was to determine which previously published KCNQ1 case variants are likely false positives.
METHODS: A list of all published, case-derived KCNQ1 missense variants (MVs) was compiled. The occurrence of each MV within the Genome Aggregation Database (gnomAD) was assessed. Eight in silico tools were used to predict each variant's pathogenicity. Case-derived variants that were either (1) too frequently found in gnomAD or (2) absent in gnomAD but predicted to be pathogenic by ≤2 tools were considered potential false positives. Three of these variants were characterized functionally using whole-cell patch clamp technique.
RESULTS: Overall, there were 244 KCNQ1 case-derived MVs. Of these, 29 (12%) were seen in ≥10 individuals in gnomAD and are demotable. However, 157 of 244 MVs (64%) were absent in gnomAD. Of these, 7 (4%) were predicted to be pathogenic by ≤2 tools, 3 of which we characterized functionally. There was no significant difference in current density between heterozygous KCNQ1-F127L, -P477L, or -L619M variant-containing channels compared to KCNQ1-WT.
CONCLUSION: This study offers preliminary evidence for the demotion of 32 (13%) previously published LQT1 MVs. Of these, 29 were demoted because of their frequent sighting in gnomAD. Additionally, in silico analysis and in vitro functional studies have facilitated the demotion of 3 ultra-rare MVs (F127L, P477L, L619M).
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Genetics; Heart arrest; KCNQ1; Long QT syndrome; Pediatrics

Mesh:

Substances:

Year:  2017        PMID: 29197658      PMCID: PMC6383800          DOI: 10.1016/j.hrthm.2017.11.032

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  21 in total

1.  Prevalence of the congenital long-QT syndrome.

Authors:  Peter J Schwartz; Marco Stramba-Badiale; Lia Crotti; Matteo Pedrazzini; Alessandra Besana; Giuliano Bosi; Fulvio Gabbarini; Karine Goulene; Roberto Insolia; Savina Mannarino; Fabio Mosca; Luigi Nespoli; Alessandro Rimini; Enrico Rosati; Patrizia Salice; Carla Spazzolini
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

2.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

3.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

4.  Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.

Authors:  Michael J Ackerman; Igor Splawski; Jonathan C Makielski; David J Tester; Melissa L Will; Katherine W Timothy; Mark T Keating; Gregg Jones; Monica Chadha; Christopher R Burrow; J Claiborne Stephens; Chuanbo Xu; Richard Judson; Mark E Curran
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

5.  Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.

Authors:  M B Rook; C Bezzina Alshinawi; W A Groenewegen; I C van Gelder; A C van Ginneken; H J Jongsma; M M Mannens; A A Wilde
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

6.  Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.

Authors:  J Erdmann; S Daehmlow; S Wischke; M Senyuva; U Werner; J Raible; N Tanis; S Dyachenko; M Hummel; R Hetzer; V Regitz-Zagrosek
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

7.  Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.

Authors:  Michael J Ackerman; David J Tester; Gregg S Jones; Melissa L Will; Christopher R Burrow; Mark E Curran
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

8.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Authors:  Jamie D Kapplinger; David J Tester; Benjamin A Salisbury; Janet L Carr; Carole Harris-Kerr; Guido D Pollevick; Arthur A M Wilde; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-06-23       Impact factor: 6.343

9.  Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.

Authors:  Suraj Kapa; David J Tester; Benjamin A Salisbury; Carole Harris-Kerr; Manish S Pungliya; Marielle Alders; Arthur A M Wilde; Michael J Ackerman
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

10.  Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.

Authors:  Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Raffaella Bloise; Elena Ronchetti; Janni Nastoli; Georgia Bottelli; Marina Cerrone; Sergio Leonardi
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

View more
  5 in total

1.  Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.

Authors:  Jeffrey S Bennett; Madison Bernhardt; Kim L McBride; Shalini C Reshmi; Erik Zmuda; Naomi J Kertesz; Vidu Garg; Sara Fitzgerald-Butt; Anna N Kamp
Journal:  Pediatr Cardiol       Date:  2019-09-18       Impact factor: 1.655

2.  Growing Pains in Cardiovascular Genetics.

Authors:  Dan M Roden
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

3.  Reclassification of genetic variants in children with long QT syndrome.

Authors:  Dominik S Westphal; Tobias Burkard; Alexander Moscu-Gregor; Roman Gebauer; Gabriele Hessling; Cordula M Wolf
Journal:  Mol Genet Genomic Med       Date:  2020-05-08       Impact factor: 2.183

4.  Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer.

Authors:  Qingzhu Jia; Qian Chu; Anmei Zhang; Jing Yu; Fangfang Liu; Kaiyu Qian; Yu Xiao; Xue Wang; Ying Yang; Yi Zhao; Ji He; Guanghui Li; Yisong Y Wan; Conghua Xie; Bo Zhu
Journal:  Commun Biol       Date:  2021-01-29

5.  A computational model of induced pluripotent stem-cell derived cardiomyocytes for high throughput risk stratification of KCNQ1 genetic variants.

Authors:  Divya C Kernik; Pei-Chi Yang; Junko Kurokawa; Joseph C Wu; Colleen E Clancy
Journal:  PLoS Comput Biol       Date:  2020-08-14       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.